Long-term 6-year experience with finasteride in patients with benign prostatic hyperplasia

Author： Lowe F.C.   McConnell J.D.   Hudson P.B.   Romas N.A.   Boake R.   Lieber M.   Elhilali M.   Geller J.   Imperto-McGinely J.   Andriole G.L.   Bruskewitz R.C.   Walsh P.C.   Bartsch G.   Nacey J.N.   Shah S.   Pappas F.   Ko A.   Cook T.   Stoner E.   Waldstreicher J.   FINASTERIDE STUDY GROUP  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.61, Iss.4, 2003-04, pp. : 791-796

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia

By Vaughan D.   Imperato-McGinley J.   McConnell J.   Matsumoto A.M.   Bracken B.   Roy J.   Sullivan M.   Pappas F.   Cook T.   Daurio C.   Meehan A.   Stoner E.   Waldstreicher J.  

Urology, Vol. 60, Iss. 6, 2002-12 ,pp. : 1040-1044

Elsevier

Access to resources Recommend Favorite

Long-term treatment with finasteride in men with symptomatic benign prostatic hyperplasia: 10-year follow-up

By Lam J.S.   Romas N.A.   Lowe F.C.  

Urology, Vol. 61, Iss. 2, 2003-02 ,pp. : 354-358

Elsevier

Access to resources Recommend Favorite

Long-term efficacy and safety of terazosin in patients with benign prostatic hyperplasia

By Lepor H.  

Urology, Vol. 45, Iss. 3, 1995-03 ,pp. : 406-413

Elsevier

Access to resources Recommend Favorite

Effects of finasteride on hematuria associated with benign prostatic hyperplasia: long-term follow-up

By Miller M.I.   Puchner P.J.  

Urology, Vol. 51, Iss. 2, 1998-02 ,pp. : 237-240

Elsevier

Access to resources Recommend Favorite

Long-term outcome of prostatic stent treatment for benign prostatic hyperplasia

By Chiou R.K.   Chen W.S.   Akbari A.   Foley S.   Lynch B.   Taylor R.J.  

Urology, Vol. 48, Iss. 4, 1996-10 ,pp. : 589-593

Elsevier

Access to resources Recommend Favorite